Werner Geldenhuys
Title
Cited by
Cited by
Year
Pharmacology and structure‐activity relationships of bioactive polycyclic cage compounds: A focus on pentacycloundecane derivatives
WJ Geldenhuys, SF Malan, JR Bloomquist, AP Marchand, ...
Medicinal research reviews 25 (1), 21-48, 2005
2172005
Oxidative stress and Alzheimer’s disease: dietary polyphenols as potential therapeutic agents
AS Darvesh, RT Carroll, A Bishayee, WJ Geldenhuys, CJ Van der Schyf
Expert review of neurotherapeutics 10 (5), 729-745, 2010
2052010
Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells
JA Gaasch, PR Lockman, WJ Geldenhuys, DD Allen, CJ Van der Schyf
Neurochemical research 32 (7), 1196-1208, 2007
1962007
Curcumin and neurodegenerative diseases: a perspective
AS Darvesh, RT Carroll, A Bishayee, NA Novotny, WJ Geldenhuys, ...
Expert opinion on investigational drugs 21 (8), 1123-1140, 2012
1402012
Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers
W Geldenhuys, T Mbimba, T Bui, K Harrison, V Sutariya
Journal of drug targeting 19 (9), 837-845, 2011
1312011
Optimizing the use of open-source software applications in drug discovery
WJ Geldenhuys, KE Gaasch, M Watson, DD Allen, CJ Van der Schyf
Drug discovery today 11 (3-4), 127-132, 2006
1222006
Multifunctional drugs with different CNS targets for neuropsychiatric disorders
CJ Van der Schyf, WJ Geldenhuys, MBH Youdim
Journal of neurochemistry 99 (4), 1033-1048, 2006
982006
The emergence of designed multiple ligands for neurodegenerative disorders
WJ Geldenhuys, MBH Youdim, RT Carroll, CJ Van der Schyf
Progress in neurobiology 94 (4), 347-359, 2011
902011
NGP1-01, a lipophilic polycyclic cage amine, is neuroprotective in focal ischemia
A Mdzinarishvili, WJ Geldenhuys, TJ Abbruscato, U Bickel, J Klein, ...
Neuroscience letters 383 (1-2), 49-53, 2005
852005
Paclitaxel–hyaluronic nanoconjugates prolong overall survival in a preclinical brain metastases of breast cancer model
RK Mittapalli, X Liu, CE Adkins, MI Nounou, KA Bohn, TB Terrell, ...
Molecular cancer therapeutics 12 (11), 2389-2399, 2013
842013
Role of serotonin in Alzheimer’s disease
WJ Geldenhuys, CJ Van der Schyf
CNS drugs 25 (9), 765-781, 2011
832011
Brain-targeted delivery of Tempol-loaded nanoparticles for neurological disorders
RT Carroll, D Bhatia, W Geldenhuys, R Bhatia, N Miladore, A Bishayee, ...
Journal of drug targeting 18 (9), 665-674, 2010
832010
Rationally designed multi-targeted agents against neurodegenerative diseases
W J Geldenhuys, C J Van der Schyf
Current medicinal chemistry 20 (13), 1662-1672, 2013
812013
The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer’s disease
WJ Geldenhuys, CJ Van der Schyf
Expert review of neurotherapeutics 9 (7), 1073-1085, 2009
802009
Multifunctional neuroprotective drugs targeting monoamine oxidase inhibition, iron chelation, adenosine receptors, and cholinergic and glutamatergic action for …
CJ Van der Schyf, S Gal, WJ Geldenhuys, MBH Youdim
Expert opinion on investigational drugs 15 (8), 873-886, 2006
782006
Molecular insights into human monoamine oxidase B inhibition by the glitazone antidiabetes drugs
C Binda, M Aldeco, WJ Geldenhuys, M Tortorici, A Mattevi, ...
ACS medicinal chemistry letters 3 (1), 39-42, 2012
772012
In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery
AS Darvesh, RT Carroll, WJ Geldenhuys, GA Gudelsky, J Klein, ...
Expert opinion on drug discovery 6 (2), 109-127, 2011
742011
Synthesis and biological evaluation of pentacyclo [5.4. 0.02, 6.03, 10.05, 9] undecane derivatives as potential therapeutic agents in Parkinson's disease
WJ Geldenhuys, SF Malan, T Murugesan, CJ Van der Schyf, ...
Bioorganic & medicinal chemistry 12 (7), 1799-1806, 2004
722004
Serotonin 5-HT6 receptor antagonists for the treatment of Alzheimer's disease
WJ Geldenhuys, CJ Van der Schyf
Current topics in medicinal chemistry 8 (12), 1035-1048, 2008
712008
Pharmacotherapy of Alzheimer’s disease: current and future trends
WJ Geldenhuys, AS Darvesh
Expert review of neurotherapeutics 15 (1), 3-5, 2015
672015
The system can't perform the operation now. Try again later.
Articles 1–20